|
No images? Click here
SPP-ARC NewsletterJanuary 2026 Upcoming Events
Integrated Trainee SeminarJoin us on Wednesday Jan. 14 to hear about some of the exciting research at SPP-ARC. The presenting trainees this month are:
Featured Publication - Biosecurity
SPP-ARC members teamed up with investigators from the National Microbiology Laboratory to study possible treatments against a security sensitive virus. Crimean-Congo hemorrhagic fever virus (CCHFV) is a segmented, single-stranded, negative-sense RNA virus that belongs to the family Nairoviridae. The virus is endemic in Europe, Africa and Asia and causes severe human disease with high case fatality rates. For these reasons, CCHFV is widely considered a priority pathogen that represents a significant biosecurity concern. CCFHV research is required to develop effective medical countermeasures. This study provides evidence to support the development of mutagenic nucleotides as antiviral drugs for the treatment of CCHFV infection. PublicationsSPP-ARC's members continue to carry out exciting research. Some of our most recent publications are:
In the NewsDr. Tyrrell promoted to companion
Congratulations to Dr. Lorne Tyrrell who was promoted to companion the highest appointment in the Order of Canada. He was first appointed to the order in 2022. Nurturing the future of pandemic expertise
Hery Lee (Götte lab) and Ksenia Rybkina (director of training) spoke with the faculty's editorial team about SPP-ARC's training program and it's interdisciplinary approach. E. coli use new way to protect themselves during Crohn’s disease, study finds
Jonas Wong and Wael Elhenawy spoke to the editorial team at Folio about their study recently published in Nature Communications and the impact on a mortality leading disease. CBC Radio segment on the Alberta cryo-em facility
CBC's Liam Harrap spoke with Matthias Götte (director of SPP-ARC) about the facility and it's impact in the study of emerging threats and the rapid development of medical countermeasures.
|